| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8234980 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 7 Pages |
Abstract
These data demonstrate that hypofractionated radiotherapy using IMRT for prostate cancer is well tolerated with minimal late toxicity at 2 years posttreatment. Ongoing studies are looking at the efficacy of hypofractionated regimes with respect to biological control.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Joanna H. FRCR., James P. FRCR., Richard A. FRCR., John P. FRCR., Ric M.Sc., Jacqueline E. FRCR.,